COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS
An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloproste...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TUCKER, Ian George EMSLIE, Forbes Richard WALKER, Greg BHUSAL, Prabhat MCDOUGALL, Scott |
| description | An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloprostenol.
L'invention concerne une composition injectable à libération prolongée comprenant une prostaglandine, formulée pour libérer la prostaglandine de manière prolongée, et une méthode d'induction de la lutéolyse d'un corps luteum fonctionnel chez un animal par l'administration prolongée d'une prostaglandine telle que PGF2α, de préférence la cloprosténol. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024218609A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024218609A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024218609A13</originalsourceid><addsrcrecordid>eNrjZNBz9vcN8A_2DPH091Nw9HNR8HUN8fB3UXDzD1Lw9HMJdfb0c1fwCQ1x9feJDPYM5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJkaGFmYGlo6GxsSpAgCRrCbm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS</title><source>esp@cenet</source><creator>TUCKER, Ian George ; EMSLIE, Forbes Richard ; WALKER, Greg ; BHUSAL, Prabhat ; MCDOUGALL, Scott</creator><creatorcontrib>TUCKER, Ian George ; EMSLIE, Forbes Richard ; WALKER, Greg ; BHUSAL, Prabhat ; MCDOUGALL, Scott</creatorcontrib><description>An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloprostenol.
L'invention concerne une composition injectable à libération prolongée comprenant une prostaglandine, formulée pour libérer la prostaglandine de manière prolongée, et une méthode d'induction de la lutéolyse d'un corps luteum fonctionnel chez un animal par l'administration prolongée d'une prostaglandine telle que PGF2α, de préférence la cloprosténol.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241024&DB=EPODOC&CC=WO&NR=2024218609A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241024&DB=EPODOC&CC=WO&NR=2024218609A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TUCKER, Ian George</creatorcontrib><creatorcontrib>EMSLIE, Forbes Richard</creatorcontrib><creatorcontrib>WALKER, Greg</creatorcontrib><creatorcontrib>BHUSAL, Prabhat</creatorcontrib><creatorcontrib>MCDOUGALL, Scott</creatorcontrib><title>COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS</title><description>An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloprostenol.
L'invention concerne une composition injectable à libération prolongée comprenant une prostaglandine, formulée pour libérer la prostaglandine de manière prolongée, et une méthode d'induction de la lutéolyse d'un corps luteum fonctionnel chez un animal par l'administration prolongée d'une prostaglandine telle que PGF2α, de préférence la cloprosténol.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz9vcN8A_2DPH091Nw9HNR8HUN8fB3UXDzD1Lw9HMJdfb0c1fwCQ1x9feJDPYM5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJkaGFmYGlo6GxsSpAgCRrCbm</recordid><startdate>20241024</startdate><enddate>20241024</enddate><creator>TUCKER, Ian George</creator><creator>EMSLIE, Forbes Richard</creator><creator>WALKER, Greg</creator><creator>BHUSAL, Prabhat</creator><creator>MCDOUGALL, Scott</creator><scope>EVB</scope></search><sort><creationdate>20241024</creationdate><title>COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS</title><author>TUCKER, Ian George ; EMSLIE, Forbes Richard ; WALKER, Greg ; BHUSAL, Prabhat ; MCDOUGALL, Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024218609A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TUCKER, Ian George</creatorcontrib><creatorcontrib>EMSLIE, Forbes Richard</creatorcontrib><creatorcontrib>WALKER, Greg</creatorcontrib><creatorcontrib>BHUSAL, Prabhat</creatorcontrib><creatorcontrib>MCDOUGALL, Scott</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TUCKER, Ian George</au><au>EMSLIE, Forbes Richard</au><au>WALKER, Greg</au><au>BHUSAL, Prabhat</au><au>MCDOUGALL, Scott</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS</title><date>2024-10-24</date><risdate>2024</risdate><abstract>An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloprostenol.
L'invention concerne une composition injectable à libération prolongée comprenant une prostaglandine, formulée pour libérer la prostaglandine de manière prolongée, et une méthode d'induction de la lutéolyse d'un corps luteum fonctionnel chez un animal par l'administration prolongée d'une prostaglandine telle que PGF2α, de préférence la cloprosténol.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2024218609A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T11%3A17%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TUCKER,%20Ian%20George&rft.date=2024-10-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024218609A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |